Industry

KNOXVILLE, Tenn.–(BUSINESS WIRE)–ChoiceSpine LLC, a privately-held spinal device manufacturer based in Knoxville, TN, announces the launch of an additional lordotic offering for their stand-alone anterior lumbar interbody – Harrier SA. Harrier SA is a 3D printed stand-alone screw-based system incorporating ChoiceSpine’s proprietary BioBond™ porous structure technology. The system has had great success since launching in … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Biophotonics Market, by End Use, by Application, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. Based on application, market is segmented into see through imaging, inside imaging, spectro molecular, surface imaging, microscopy, light therapy, biosensors, and other analytic sensing. Furthermore, based … [Read more…]

NORWALK, Conn.–(BUSINESS WIRE)–#betheproof–Shatterproof Just Five, an online, self-paced, mobile enabled program that increases awareness, reduces stigma, and shares information about addiction prevention and treatment was recently evaluated in PLOS ONE. The peer-reviewed, open-access scientific journal published by the Public Library of Science covers primary research from all disciplines within science and medicine. The evaluation of … [Read more…]

SOMERVILLE, Mass. & MENLO PARK, Calif.–(BUSINESS WIRE)–CIBC Innovation Banking is pleased to announce a $25 million debt financing for Massachusetts-based Podimetrics Inc. (“Podimetrics”), an integrated clinical care service company that helps prevent amputations in patients suffering from complex diabetes. Podimetrics plans to use the growth capital to expand its commercial operations. Founded in 2011, Podimetrics … [Read more…]

With a Shared Vision, the Two Companies Partner to Expand Access to Mental Health Services in Montana and Beyond DALLAS–(BUSINESS WIRE)–Turnwell Mental Health Network and Montana Psychiatry & Brain Health Center (“Montana Psychiatry”), a leading provider of psychiatric services, announced today that they have finalized a growth partnership. With this partnership, they plan to expand … [Read more…]

IRVINE, Calif.–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) today announced that its management will participate in the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022 at 8:30 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) today announced that Joshua Cohen and Justin Klee, Co-CEOs of Amylyx, will participate in the Evercore ISI 5th Annual HealthCONx Conference. The conference is being conducted in a virtual format, and the fireside chat will take place on Tuesday, November 29, 2022 at 3:05 p.m. ET. A live … [Read more…]

BOSTON–(BUSINESS WIRE)–OcuTerra Therapeutics, Inc. (“OcuTerra”), a clinical stage ophthalmology company developing innovative drugs to treat ophthalmic diseases for which the current standard of care of “watch-and-wait” does not prevent or control the progression of disease, today announced the company’s participation in two upcoming investor conferences. OcuTerra CEO & President Kerrie Brady, BPharm, MS, MBA, will … [Read more…]

DALLAS–(BUSINESS WIRE)–$LTRN–Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (“A.I.”) and machine learning (“M.L.”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it presented positive preclinical data on the efficacy of its drug candidate LP-184 for glioblastoma (GBM), … [Read more…]

New real-world evidence further supports the efficacy and use of ReActiv8® Restorative Neurostimulation™ for the treatment of intractable Chronic Low Back Pain DUBLIN–(BUSINESS WIRE)–Mainstay Medical Holdings plc today announced the publication of data from a single center, real-world study with one-year clinical follow-up of patients selected from the ReActiv8®-C study. Patients implanted with ReActiv8 at … [Read more…]